Daniel E. Geffken
Director, Cyberkinetics Neurotechnology Systems, Inc.
Companies
- CalciMedica, Inc.Chief financial officer May 3, 2023 to May 20, 20241
- CERO THERAPEUTICS HOLDINGS, INC.Chief financial officer Oct 5, 2021 to Feb 16, 20242
- ProMIS Neurosciences Inc.Chief financial officer Jul 7, 2022 to Oct 30, 20233
- WINDTREE THERAPEUTICS INC /DE/Board member Apr 26, 2019 to Aug 29, 20234
- Eloxx Pharmaceuticals, Inc.Chief financial officer Apr 2, 2021 to Dec 1, 20215
- eFFECTOR Therapeutics, Inc.Chief financial officer Jan 7, 2021 to Jan 14, 20216
- Adhera Therapeutics, Inc.Chief financial officer Jun 2, 2014 to Jun 2, 20147
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Eloxx Pharmaceuticals, Inc. ELOX50,000 shares8$651.5K at $13.03Nov 29, 2021
- ProMIS Neurosciences Inc. PMN5,852 shares9$50.9K at $8.70Jul 7, 2022
- CERO THERAPEUTICS HOLDINGS, INC. CERO10,002 shares10$63 at $0.01Feb 14, 2024
- WINDTREE THERAPEUTICS INC /DE/ WINT2,175 shares11$2 at $0.00Aug 23, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 14, 2024Other 10,002 shares of CERO THERAPEUTICS HOLDINGS, INC.10
- Aug 23, 2023Granted 2,033 shares of WINDTREE THERAPEUTICS INC /DE/11
- Jun 7, 2022Granted 5,000 shares of WINDTREE THERAPEUTICS INC /DE/12
- Nov 29, 2021Bought 50,000 shares at $0.72 of Eloxx Pharmaceuticals, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed Jun 9, 2022